SCHEMBL331866

SCHEMBL331866

C=C(C)C(=O)OCC(O)COC(CC)C([SiH3])(O[Si](C)(C)C)O[Si](C)(C)C

nearest known ligand 0.40

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.39
THRB P10828 1/20 0.31
ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL35421 0.87 TDP1 (0.31) ALDH1A1
SCHEMBL332528 0.79
SCHEMBL8356574 0.79 TSHR (0.45) TSHRTHRBALDH1A1
SCHEMBL9842186 0.78 TSHR (0.47) TSHRTHRBALDH1A1
SCHEMBL758665 0.78 TSHR (0.33) TSHRTHRBALDH1A1
SCHEMBL642805 0.78 TSHR (0.44) TSHRTHRBALDH1A1
SCHEMBL29011415 0.76 TSHR (0.45) TSHRTHRBALDH1A1
SCHEMBL18171346 0.75 TSHR (0.39) TSHRALDH1A1
SCHEMBL2189996 0.74 TSHR (0.41) TSHRTHRBALDH1A1
SCHEMBL10980730 0.73 TSHR (0.41) TSHRTHRBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 498 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260042268-A1 SILICONE HYDROGEL LENSES WITH WATER-RICH SURFACES ALCON INC (CH) 2026-02-12 US claimed
US-20260042269-A1 SILICONE HYDROGEL LENSES WITH WATER-RICH SURFACES ALCON INC (CH) 2026-02-12 US claimed
EP-4657145-A2 SILICONE HYDROGEL LENSES WITH WATER-RICH SURFACES Alcon Inc. (CH) 2025-12-03 EP claimed
EP-4657144-A2 SILICONE HYDROGEL LENSES WITH WATER-RICH SURFACES Alcon Inc. (CH) 2025-12-03 EP claimed
US-20250223392-A1 HYDROPHILIZED POLYDIORGANOSILOXANE VINYLIC CROSSLINKERS AND USES THEREOF ALCON INC (CH) 2025-07-10 US claimed
US-12286501-B2 Hydrophilized polydiorganosiloxane vinylic crosslinkers and uses thereof ALCON INC. (CH) 2025-04-29 US claimed
US-20240254269-A1 HYDROPHILIZED POLYDIORGANOSILOXANE VINYLIC CROSSLINKERS AND USES THEREOF ALCON INC. (CH) 2024-08-01 US claimed
WO-2024065567-A1 SILOXANE MONOMER, CONTACT LENS COMPOSITION AND CONTACT LENS 晶硕光学股份有限公司 2024-04-04 WO claimed
WO-2024054562-A2 SUPRAMOLECULAR HYBRID HYDROGELS FOR BURN AND WOUND DRESSINGS TRUSTEES OF TUFTS COLLEGE (US) 2024-03-14 WO claimed
US-11926689-B2 Hydrophilized polydiorganosiloxane vinylic crosslinkers and uses thereof ALCON INC. (CH) 2024-03-12 US claimed
EP-1560043-B1 Soft contact lenses JOHNSON & JOHNSON VISION CARE (US) 2008-06-18 EP claimed
US-20070229757-A1 BIOMEDICAL DEVICES CONTAINING INTERNAL WETTING AGENTS JOHNSON & JOHNSON VISION CARE, INC. 2007-10-04 US claimed
EP-1809344-A2 BIOMEDICAL DEVICES CONTAINING AMPHIPHILIC BLOCK COPOLYMERS Johnson and Johnson Vision Care, Inc. (US) 2007-07-25 EP claimed
US-7247692-B2 Biomedical devices containing amphiphilic block copolymers JOHNSON & JOHNSON VISION CARE, INC. (US) 2007-07-24 US claimed
WO-2006039467-A2 BIOMEDICAL DEVICES CONTAINING AMPHIPHILIC BLOCK COPOLYMERS JOHNSON & JOHNSON VISION CARE, INC. (US) 2006-04-13 WO claimed
US-20060074208-A1 Biomedical devices containing amphiphilic block copolymers JOHNSON & JOHNSON VISION CARE, INC. 2006-04-06 US claimed
EP-1641863-A2 SILICONE HYDROGELS HAVING CONSISTENT CONCENTRATIONS OF MULTI-FUNCTIONAL POLYSILOXANES Johnson & Johnson Vision Care, Inc. (US) 2006-04-05 EP claimed
US-20050255231-A1 Silicone hydrogels having consistent concentrations of multi-functional polysiloxanes JOHNSON & JOHNSON VISION CARE, INC. 2005-11-17 US claimed
EP-0940693-B1 Soft contact lenses JOHNSON & JOHNSON VISION CARE (US) 2005-06-22 EP claimed
WO-2005005517-A2 SILICONE HYDROGELS HAVING CONSISTENT CONCENTRATIONS OF MULTI-FUNCTIONAL POLYSILOXANES JOHNSON & JOHNSON VISION CARE, INC. (US) 2005-01-20 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260042269-A1 SILICONE HYDROGEL LENSES WITH WATER-RICH SURFACES CRYZ, STRA6, PHOSPHO1 TSHR 2055/4885THRB 2097/4885ALDH1A1 1714/4885
US-20260042268-A1 SILICONE HYDROGEL LENSES WITH WATER-RICH SURFACES STRA6, CRYZ, SMCHD1 TSHR 1985/4885THRB 2866/4885ALDH1A1 969/4885
US-20050255231-A1 Silicone hydrogels having consistent concentrations of multi-functional polysiloxanes MMS19, FHIT, CAD TSHR 4175/4885THRB 2958/4885ALDH1A1 1533/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.